Cardiff, United Kingdom

Timothy John Kenhardt Gibs

This inventor holds 1 USPTO granted patent. Top assignee: Vantia Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy John Kenhardt Gibs. Retrieved from https://idiyas.com/inventor/timothy-john-kenhardt-gibs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy John Kenhardt Gibs

Introduction

Timothy John Kenhardt Gibs is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals through his innovative work. His expertise and dedication have led to the development of a unique patent that showcases his inventive capabilities.

Latest Patents

Timothy holds a patent for the Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4,10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide. This invention provides a pharmaceutical composition that includes cyclopropanecarboxylic acid para-toluenesulphonate, which has potential therapeutic applications. His work in this area highlights the importance of innovative solutions in the pharmaceutical industry.

Career Highlights

Timothy is associated with Vantia Limited, where he continues to contribute to advancements in pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of Timothy's coworkers include Andrzej Roman Batt and Rachel Louisa Charlotte Handy. Their collective efforts contribute to the innovative environment at Vantia Limited.

Conclusion

Timothy John Kenhardt Gibs exemplifies the spirit of innovation in the pharmaceutical sector. His patent and ongoing work at Vantia Limited demonstrate his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…